Cost Analysis Comparison of Single Ceftriaxone And Combination With Other Antibiotics In Patients With Community-Acquired Pneumonia]According to IDSA, Community Acquired Pneumonia (CAP) is an acute infection Parenkim lung that is defined by the presence of a new filtrate in a thoracic photograph or the discovery of breath sound changes and local wet ronkhi on a lung physical examination that are consistent with pneumonia in patients who have not been hospitalized or received other care within 14 days prior to the onset of symptoms. Community-acquired pneumonia improves clinically within 72 hours of initial antibiotic administration. In this study, single ceftriaxone and ceftriaxone in combination with other antibiotics were used to treat community pneumonia at the X Hospital in 2020. According to data from X Hospital, female patients were more likely to suffer from community pneumonia. Treatment of community-acquired pneumonia aims to compare antibiotic use based on a Cost Effective Analysis (CEA). The outcome category is based on the patient's condition upon return home, as well as direct and long-term medical costs. According to the results of the Acer's AverageCost Effectiveness Ratio (ACER), which uses a single ceftriaxone antibiotic therapy at a cost of Rp. 281.113 per day for duration of four days and patients who receive ceftriaxone therapy in combination with other antibiotics at a cost of Rp. 720,276 per day for a duration of three days. The results of this study indicate that single ceftriaxone therapy is more cost effective than ceftriaxone therapy in combination with other antibiotics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.